Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Employee and Director Benefits

v3.19.1
Note 7 - Employee and Director Benefits
3 Months Ended
Mar. 31, 2019
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
NOTE
7
- EMPLOYEE AND DIRECTOR BENEFITS
 
Stock Options
 
At
March 31, 2019,
the Company had stock incentive plans as described below. The compensation cost that has been charged to earnings for the plans was approximately
$0.3
million and
$0.2
million for the
three
months ended
March 31, 2019
and
2018,
respectively.
 
The Company’s
2009
Amended and Restated Stock Incentive Plan authorizes the grant of up to
5,550,000
shares and allows for the issuance of Stock Appreciation Rights, Restricted Stock, Stock Options, Non-stock Share Equivalents, Performance Shares or Performance Units. Both plans allow for the grant of incentive stock options and non-qualified stock options, and option awards are granted with an exercise price equal to the fair market value of the Company’s common stock at the date of grant. The maximum term of the options granted under the plans is
ten
years.
 
The Company estimates the fair value of each stock option award using a Black-Scholes-Merton valuation model which incorporates the assumptions noted in the following table. Expected volatilities are based on an index of southeastern United States publicly traded banks. The expected term for options granted is based on the short-cut method and represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the contractual life of the option is based on the U. S. Treasury yield curve in effect at the time of grant.
 
    2019   2018
Expected volatility    
40.00
%    
23.43
%
Expected dividends    
1.76
%    
1.07
%
Expected term (in years)    
6.3
     
6.3
 
Risk-free rate    
2.61
%    
2.67
%
 
The weighted average grant-date fair value of options granted during the
three
months ended
March 31, 2019
and
2018
was
$12.20
and
$10.41,
respectively.
 
The following table summarizes stock option activity during the
three
months ended
March 31, 2019
and
2018:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shares
 
 
 
 
 
 
Weighted
Average
Exercise
Price
 
 
 
 
 
Weighted
Average
Remaining
Contractual
Term (years)
 
 
 
 
 
 
 
 
Aggregate
Intrinsic Value
                (In Thousands)
Three Months Ended March 31, 2019:                                
Outstanding January 1, 2019    
1,238,748
    $
13.02
     
5.2
    $
23,355
 
Granted    
6,000
     
34.09
     
9.8
     
(2
)
Exercised    
(162,500
)    
4.59
     
1.7
     
4,384
 
Forfeited    
     
     
     
 
Outstanding March 31, 2019    
1,082,248
     
14.41
     
6.3
    $
21,318
 
                                 
Exercisable March 31, 2019    
354,800
    $
8.40
     
4.0
    $
9,356
 
                                 
Three Months Ended March 31, 2018:                                
Outstanding January 1, 2018    
1,666,834
    $
10.68
     
5.5
    $
51,377
 
Granted    
10,250
     
41.21
     
9.9
     
(4
)
Exercised    
(173,836
)    
4.90
     
3.4
     
6,244
 
Forfeited    
(1,000
)    
25.41
     
8.5
     
15
 
Outstanding March 31, 2018    
1,502,248
     
11.54
     
5.5
    $
43,978
 
                                 
Exercisable March 31, 2018    
672,600
    $
5.48
     
3.9
    $
23,770
 
 
As of
March 31, 2019,
there was
$1.6
million of total unrecognized compensation cost related to non-vested stock options. The cost is expected to be recognized on the straight-line method over the next
1.8
years.
 
Restricted Stock
 
The Company periodically grants restricted stock awards that vest upon service conditions. Dividend payments are made during the vesting period. The value of restricted stock is determined to be the current value of the Company’s stock, and this total value will be recognized as compensation expense over the vesting period. There were
15,200
shares of restricted stock granted to employees during the
first
quarter of
2019.
There were
10,750
shares of restricted stock granted to employees during the
first
quarter of
2018.
As of
March 31, 2019,
there was
$1.2
million of total unrecognized compensation cost related to non-vested restricted stock. As of
March 31, 2019,
non-vested restricted stock had a weighted average remaining time to vest of
3.2
years.